Qbtech is a global leader in medical technology focused exclusively on transforming ADHD care. Founded in 2002, the company has developed the world’s first FDA-cleared, CE-marked device for objective ADHD assessment — now trusted by clinicians in more than 13 countries and across 43 states in the U.S.
QbTest is designed for use in both children and adults (ages 6–60). It is the only tool of its kind cleared by the U.S. Food and Drug Administration for both diagnosis and treatment follow-up in ADHD care.
Qbtech’s mission is simple: to provide the most accurate and reliable ADHD testing tools available, supporting better outcomes and better lives.Treatment for ADHD is multifaceted and includes behavioral, pharmacological, and supportive interventions.
